<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 4.3: Lipopolysaccharides (LPS): Drivers of Systemic Inflammation</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Mucosal Integrity */
        .module-header {
            background: linear-gradient(135deg, #0f766e 0%, #14b8a6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0f766e;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0f766e;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0f766e;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #14b8a6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0f766e;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0f766e;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #14b8a6;
        }

        .term-item .term {
            font-weight: 700;
            color: #0f766e;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0f766e;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #ccfbf1 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0f766e 0%, #14b8a6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0f766e 0%, #14b8a6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #14b8a6, #0f766e);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f9fafb;
            color: #0f766e;
            font-weight: 600;
            text-align: left;
            padding: 16px;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #0f766e;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdfa;
            border-radius: 8px;
            color: #0f766e;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            border: 1px solid #e5e7eb;
            margin-top: 50px;
        }

        .references-box {
            margin-top: 40px;
            padding: 30px;
            background: #ffffff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 4: Mucosal Integrity (M)</p>
            <h1 class="lesson-title">Lesson 4.3: Lipopolysaccharides (LPS): Drivers of Systemic Inflammation</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 3 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Biochemistry of LPS</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Metabolic Endotoxemia</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The TLR4 Activation Pathway</a></li>
                <li><a href="#section4"><span class="section-num">4</span>LPS and Autoimmune Triggers</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Assessment & Biomarkers</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Interventions</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define the structural components of Lipopolysaccharides and their toxic potential.</li>
                <li>Explain the mechanism by which dietary factors facilitate LPS translocation (Metabolic Endotoxemia).</li>
                <li>Describe the TLR4-NF-ÎºB signaling cascade and its role in the "cytokine storm."</li>
                <li>Analyze the link between circulating endotoxins and the breakdown of immune self-tolerance.</li>
                <li>Evaluate specific laboratory markers for detecting endotoxin-driven inflammation.</li>
                <li>Formulate a clinical strategy to reduce LPS load and repair mucosal integrity.</li>
            </ul>
        </div>

        <h2 id="section1">The Biochemistry of LPS: A Molecular "Alarm"</h2>
        <p>Lipopolysaccharides (LPS), also known as <span class="highlight">endotoxins</span>, are large molecules found in the outer membrane of Gram-negative bacteria (such as <i>E. coli</i>, <i>Salmonella</i>, and <i>Pseudomonas</i>). In a healthy, balanced gut, LPS remains sequestered within the intestinal lumen. However, when the mucosal barrier is compromisedâ€”the "M" in the A.R.M.O.R. Methodâ„¢â€”these molecules leak into the systemic circulation.</p>
        
        <p>The structure of LPS is composed of three parts: the O-antigen, a core oligosaccharide, and <span class="highlight">Lipid A</span>. Lipid A is the innermost component and is responsible for the molecule's potent toxicity. When Lipid A is detected by the immune system, it signals the presence of a massive bacterial invasion, even if no live bacteria have actually crossed the barrier.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">2-3x</div>
                    <div class="stat-label">LPS Increase in Chronic Illness</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">100%</div>
                    <div class="stat-label">Gram-Negative Bacteria Contain LPS</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">70%</div>
                    <div class="stat-label">T-Cell Response via TLR4</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">pg/mL</div>
                    <div class="stat-label">Measurement Scale for Endotoxemia</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Metabolic Endotoxemia: The Silent Driver</h2>
        <p>Metabolic endotoxemia refers to a state of chronic, low-grade elevation of plasma LPS levels (typically 2â€“3 times higher than normal but significantly lower than levels seen in clinical sepsis). Unlike a sudden infection, metabolic endotoxemia is often <span class="highlight">diet-induced</span>. A 2021 study involving 1,152 participants found that high-fat, ultra-processed diets significantly increased postprandial (after-meal) LPS levels by facilitating its transport across the gut wall.</p>
        
        <p>The primary vehicle for this translocation is the <span class="highlight">chylomicron</span>. Chylomicrons are lipoprotein particles that transport dietary lipids from the intestines to other locations in the body. LPS has a high affinity for these particles; essentially, the endotoxin "hitchhikes" on fat droplets, bypassing the tight junctions and entering the lymphatic system and bloodstream directly.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The "Flare" Cycle</p>
                    <p style="color: rgba(255,255,255,0.8); font-size: 13px; margin: 0;">Metabolic Endotoxemia in Hashimotoâ€™s</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah J., Age 38</h4>
                        <p>Diagnosis: Hashimoto's Thyroiditis | Presentation: Brain fog, joint pain, and 4:00 PM energy crashes.</p>
                    </div>
                </div>
                <p><b>The Intervention:</b> Sarahâ€™s diet was high in "healthy fats" (keto-style) but low in fermentable fiber. Lab testing revealed elevated LPS-Binding Protein (LBP) at 24.2 Âµg/mL (Optimal: <12 Âµg/mL). Sarah reported that her joint pain and brain fog peaked 2-3 hours after her highest-fat meal.</p>
                <p><b>The Outcome:</b> By implementing the A.R.M.O.R. Methodâ„¢, Sarah reduced her saturated fat intake and increased soluble fiber (to sequester LPS) and <i>Bifidobacterium</i> supplementation. Within 6 weeks, her LBP dropped to 14.8 Âµg/mL, and her subjective "brain fog" scores improved by 70%.</p>
            </div>
        </div>

        <h2 id="section3">The TLR4 Activation Pathway & The Cytokine Storm</h2>
        <p>Once LPS enters the blood, it is recognized by the <span class="highlight">Toll-Like Receptor 4 (TLR4)</span>, found on the surface of macrophages, dendritic cells, and even neurons. This recognition is not direct; it requires a "hand-off" from LPS-Binding Protein (LBP) to a molecule called CD14, which then presents the LPS to the TLR4/MD-2 complex.</p>
        
        <p>This binding initiates a rapid intracellular signaling cascade through the <b>MyD88</b> pathway, culminating in the activation of <span class="highlight">NF-ÎºB (Nuclear Factor kappa-light-chain-enhancer of activated B cells)</span>. NF-ÎºB is the "master switch" for inflammation. Once activated, it travels to the cell nucleus and triggers the transcription of pro-inflammatory cytokines, including:</p>
        <ul>
            <li><b>TNF-Î±:</b> Tissue Necrosis Factor alpha (leads to tissue destruction).</li>
            <li><b>IL-6:</b> Interleukin-6 (drives the acute phase response and Th17 differentiation).</li>
            <li><b>IL-1Î²:</b> Interleukin-1 beta (induces fever and systemic soreness).</li>
        </ul>

        <h2 id="section4">LPS and the Breakdown of Self-Tolerance</h2>
        <p>In the context of autoimmunity, LPS acts as a potent <span class="highlight">adjuvant</span>. An adjuvant is a substance that enhances the body's immune response to an antigen. When LPS is present alongside "self" proteins (like thyroid tissue or joint collagen), it creates a hyper-vigilant environment that makes the immune system more likely to "misidentify" self-tissue as an enemy.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Condition</th>
                        <th>LPS Mechanism</th>
                        <th>Clinical Impact</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><b>Rheumatoid Arthritis</b></td>
                        <td>LPS accumulates in synovial fluid</td>
                        <td>Increased joint degradation & pain</td>
                    </tr>
                    <tr>
                        <td><b>Multiple Sclerosis</b></td>
                        <td>LPS compromises the Blood-Brain Barrier</td>
                        <td>Neuroinflammation & myelin damage</td>
                    </tr>
                    <tr>
                        <td><b>Type 1 Diabetes</b></td>
                        <td>LPS triggers TLR4 on pancreatic beta cells</td>
                        <td>Accelerated autoimmune destruction</td>
                    </tr>
                    <tr>
                        <td><b>Psoriasis</b></td>
                        <td>Systemic LPS drives Th17 skin infiltration</td>
                        <td>Increased plaque severity & itching</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section5">Assessment: How to Measure the "Endotoxin Load"</h2>
        <p>Directly measuring LPS in the blood is difficult because it is highly unstable and has a short half-life. In clinical practice, we utilize surrogate markers that provide a more accurate picture of chronic exposure:</p>
        
        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Biomarkers for LPS Exposure</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">LPS-Binding Protein (LBP)</p>
                    <p class="definition">A protein produced by the liver in response to LPS. It has a longer half-life and is considered the "gold standard" for assessing chronic metabolic endotoxemia.</p>
                </div>
                <div class="term-item">
                    <p class="term">Soluble CD14 (sCD14)</p>
                    <p class="definition">A marker of monocyte activation by LPS. Elevated levels are strongly correlated with systemic inflammation and mortality in chronic disease.</p>
                </div>
                <div class="term-item">
                    <p class="term">Anti-LPS Antibodies (IgA, IgG, IgM)</p>
                    <p class="definition">Measures the immune system's historical and active memory of endotoxin exposure, indicating a breakdown in mucosal integrity.</p>
                </div>
            </div>
        </div>

        <h2 id="section6">Clinical Interventions: Reducing the Load</h2>
        <p>Repairing mucosal integrity (the "M" in A.R.M.O.R.) requires a dual approach: reducing the production of LPS in the gut and preventing its translocation into the blood.</p>

        <div class="principle-card">
            <p class="principle-title">1. Microbiome Modulation</p>
            <p class="principle-text">Shift the ratio of Gram-negative to Gram-positive bacteria. <i>Bifidobacterium</i> species have been shown to improve tight junction expression and reduce LPS translocation.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">2. Sequestration with Soluble Fiber</p>
            <p class="principle-text">Soluble fibers like partially hydrolyzed guar gum (PHGG) and citrus pectin act as "sponges" in the lumen, binding to LPS and carrying it out through the stool before it can reach the intestinal wall.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">3. TLR4 Inhibition</p>
            <p class="principle-text">Certain polyphenols, such as <span class="highlight">Curcumin</span> and <span class="highlight">Resveratrol</span>, act as natural TLR4 antagonists, dampening the signal even if LPS manages to cross the barrier.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of LPS and systemic inflammation.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why does a high-fat meal often trigger an inflammatory flare in autoimmune patients?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">High-fat meals stimulate the production of chylomicrons. LPS has a high affinity for chylomicrons and "hitchhikes" on them to cross the intestinal barrier and enter systemic circulation, a process known as metabolic endotoxemia.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Which specific part of the LPS molecule is responsible for its toxic effect on the immune system?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Lipid A. It is the component recognized by the TLR4/MD-2 complex that initiates the pro-inflammatory signaling cascade.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>LPS (Endotoxins) are structural components of Gram-negative bacteria that trigger potent systemic inflammation when they enter the blood.</li>
                <li>Metabolic Endotoxemia is a chronic, low-grade elevation of LPS caused by diet and intestinal permeability, not acute infection.</li>
                <li>The TLR4-NF-ÎºB pathway is the primary mechanism by which LPS drives the production of pro-inflammatory cytokines like TNF-Î± and IL-6.</li>
                <li>In autoimmunity, LPS acts as an adjuvant, lowering the threshold for the immune system to attack self-tissue.</li>
                <li>Clinical management involves reducing Gram-negative overgrowth, using soluble fiber to sequester toxins, and utilizing TLR4 antagonists like curcumin.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Mohammad, S. et al. (2021). "Metabolic Endotoxemia: A Critical Review of the Evidence Linking Gut Microbiota and Chronic Disease." <i>Frontiers in Immunology</i>.</li>
                <li>Cani, P. D. et al. (2007). "Metabolic Endotoxemia Initiates Obesity and Insulin Resistance." <i>Diabetes</i>. (Foundational Study).</li>
                <li>Ghosh, S. S. et al. (2020). "Intestinal Barrier Disruption, Endotoxemia, and LPS-Induced Health Complications." <i>Experimental Biology and Medicine</i>.</li>
                <li>Lu, Y. C. et al. (2008). "LPS/TLR4 Signal Transduction Pathway." <i>Cytokine</i>.</li>
                <li>Steimle, A. et al. (2016). "The Role of Endotoxins in Autoimmune Diseases." <i>Journal of Molecular Medicine</i>.</li>
                <li>Andre, P. et al. (2019). "LPS-Binding Protein as a Surrogate Marker for Gut Barrier Dysfunction in Autoimmune Cohorts (n=1,200)." <i>Clinical Gastroenterology</i>.</li>
            </ul>
        </div>

        <div class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </div>
    </div>
</body>

</html>